Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT03743064

Public ClinicalTrials.gov record NCT03743064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT03743064
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Helsinn Healthcare SA
Industry
Enrollment
318 participants

Conditions and interventions

Interventions

  • anamorelin HCl Drug
  • Placebo Oral Tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2019
Primary completion
Dec 26, 2022
Completion
Dec 26, 2022
Last update posted
Jun 25, 2024

2019 – 2022

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
The University of Arizona Cancer Center - North Campus Tucson Arizona 85719
Pacific Cancer Medical Center, Inc Anaheim California 92801
CBCC Global Research Inc Bakersfield California 93309
Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc. Fountain Valley California 92708
Marin Cancer Care Greenbrae California 94904
Smilow Cancer Hospital at Yale-New Haven Waterbury Connecticut 06708
Bond & Steele Clinic P.A. Winter Haven Florida 33881
Presence Infusion Care Skokie Illinois 60077
Siouxland Regional Cancer Center dba June E.Nylen Cancer Center Sioux City Iowa 51101
Cancer Center of Kansas Wichita Kansas 67214
Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan 49503
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
New Jersey Hematology Oncology Associates Inc Brick New Jersey 08724
Hunterdon Hematology Oncology LLC Flemington New Jersey 08822
Hematology Oncology Center at Nyack Hospital Nyack New York 10960
University of Rochester, Medical Center Rochester New York 14642
Duke Cancer Center Durham North Carolina 27710
Toledo Clinic Cancer Center-Toledo Toledo Ohio 43623
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03743064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03743064 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →